107 related articles for article (PubMed ID: 7656248)
1. Prognostic significance of ERBB3 overexpression in oral squamous cell carcinoma.
Shintani S; Funayama T; Yoshihama Y; Alcalde RE; Matsumura T
Cancer Lett; 1995 Aug; 95(1-2):79-83. PubMed ID: 7656248
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of Ets-1 overexpression in betel and tobacco related oral cancer.
Pande P; Soni S; Chakravarti N; Mathur M; Shukla NK; Ralhan R
Cancer Detect Prev; 2001; 25(5):496-501. PubMed ID: 11718456
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas.
Hiraishi Y; Wada T; Nakatani K; Negoro K; Fujita S
Pathol Oncol Res; 2006; 12(2):87-91. PubMed ID: 16799709
[TBL] [Abstract][Full Text] [Related]
5. Expression of a truncated epidermal growth factor receptor in oral squamous cell carcinomas.
Kiyota A; Shintani S; Mihara M; Nakahara Y; Ueyama Y; Matsumura T; Todd R; Wong DT
Cancer Lett; 2000 Dec; 161(1):9-15. PubMed ID: 11078908
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-erbB3 protein in primary breast carcinomas.
Naidu R; Yadav M; Nair S; Kutty MK
Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984
[TBL] [Abstract][Full Text] [Related]
7. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
[TBL] [Abstract][Full Text] [Related]
8. ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas.
Silva SD; Cunha IW; Younes RN; Soares FA; Kowalski LP; Graner E
Oral Dis; 2010 Nov; 16(8):774-80. PubMed ID: 20604875
[TBL] [Abstract][Full Text] [Related]
9. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck.
Ibrahim SO; Vasstrand EN; Liavaag PG; Johannessen AC; Lillehaug JR
Anticancer Res; 1997; 17(6D):4539-46. PubMed ID: 9494565
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
[TBL] [Abstract][Full Text] [Related]
11. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
12. ERBB receptors in developing, dysplastic and malignant oral epithelia.
Rautava J; Jee KJ; Miettinen PJ; Nagy B; Myllykangas S; Odell EW; Soukka T; Morgan PR; Heikinheimo K
Oral Oncol; 2008 Mar; 44(3):227-35. PubMed ID: 17604679
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma.
Huang SF; Chien HT; Chuang WY; Lai CH; Cheng SD; Liao CT; Wang HM
Sci Rep; 2017 Jul; 7(1):4963. PubMed ID: 28694429
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of erbB2 and erbB3 expression during oral oncogenesis in diabetic rats.
Vairaktaris E; Goutzanis L; Vassiliou S; Spyridonidou S; Nkenke E; Papageorgiou G; Strantzias P; Lazaris A; Yapijakis C; Patsouris E
J Cancer Res Clin Oncol; 2008 Mar; 134(3):337-44. PubMed ID: 17704947
[TBL] [Abstract][Full Text] [Related]
17. [Expression of mammary serine proteinase inhibitor in oral squamous cell carcinoma and its clinical significance].
Luo J; Zhou L; Zheng GJ; Ji T; Zhong LP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Oct; 44(10):606-10. PubMed ID: 20079307
[TBL] [Abstract][Full Text] [Related]
18. [Overexpression of C-erbB3 in transitional cell carcinoma of the ovary].
Shen K; Lang J; Guo L
Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):658-61. PubMed ID: 8745489
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of ErbB3 and ErbB4 in patients with laryngeal squamous cell carcinomas].
Ming W; Hua Q; Tao Z; Zhang D
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Aug; 21(15):706-8. PubMed ID: 17969526
[TBL] [Abstract][Full Text] [Related]
20. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
